|
Clinical predictors of sarcomatoid kidney cancer: The results of a UCLA and french UroCCR network collaboration. |
|
|
Research Funding - Pfizer (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma |
|
|
Stock and Other Ownership Interests - Allogene Therapeutics; UroGen pharma |
|
|
Honoraria - Intuitive Surgical |
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer |
Research Funding - Baxter (Inst); Intuitive Surgical (Inst); Roche (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Ipsen; Novartis; Pfizer |
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Sanofi |
Research Funding - Pfizer (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Novartis; Roche |
|
|
Travel, Accommodations, Expenses - Astellas Pharma |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Janssen; Lilly; Roche; Sanofi |
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Janssen; Lilly; Roche; Sanofi |
|
|
Honoraria - Astellas Pharma; Ipsen |
Speakers' Bureau - AstraZeneca |
Travel, Accommodations, Expenses - Janssen |
|
|
No Relationships to Disclose |
|
|
Employment - Alimera Sciences; Kronos; UroGen pharma |
Leadership - Alimera Sciences; Kronos; UroGen pharma |
Stock and Other Ownership Interests - Alimera Sciences; Kronos; UroGen pharma |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Urogen pharma |
Other Relationship - Altor BioScience |
|
|
Employment - Kyn therapeutics (I) |
Leadership - Kyn therapeutics (I) |
Stock and Other Ownership Interests - Alimera Sciences (I); UROGENE (I) |
Consulting or Advisory Role - Bristol-Myers Squibb; Kyn therapeutics |
Research Funding - Kite, a Gilead company |
Patents, Royalties, Other Intellectual Property - 5 PATENTS AT UCLA FOR 5 POTENTIAL DRUGS (I) |
Travel, Accommodations, Expenses - Lilly |
|
|
Employment - Kyn Therapeutics |
Leadership - Kyn Therapeutics |
Stock and Other Ownership Interests - Alimera Sciences; Urogene |
|
Consulting or Advisory Role - Pfizer |